Omniscan Articles

FDA call for warning on contrast agents

4 June 2007

Amersham signs off 2003 with EPS up 13%

23 February 2004

Strong growth in 2001 for Amersham

4 March 2002

Amersham 3rd-qtr sales up 10%

31 October 2001

Amersham posts strong first-half growth, stays mum on APBiotech float

7 August 2001

Nycomed Amersham profits climb 12%

10 March 1999

Nycomed Wins Contrast Media Agreement In USA

16 September 1997

Nycomed Imagers Near Market In Japan

15 April 1996

Hafslund Nycomed: European to Global Player

12 June 1995

Daiichi Sales "Exceeding Targets"

30 January 1995

Sonus Plans EchoGen NDA For Early 1995

26 September 1994

HAFSLUND RESULTS ABOVE EXPECTATION

21 February 1994

FIRST APPROVAL FOR NYCOMED'S ABDOSCAN

20 December 1993

IRINOTECAN BACKED IN JAPAN AMID CONCERNS

13 December 1993

HAFSLUND NYCOMED FIRST HALF SALES UP

9 August 1993

DAIICHI ENTERING NEW PRODUCT PHASE

26 July 1993

PENDING APPLICATIONS IN US CONTINUE TO DWINDLE

19 July 1993

HAFSLUND NYCOMED "IN A STRONG GROWTH PHASE"

22 February 1993

OMNISCAN IN THE USA

18 January 1993

STERLING-WINTHROP HAS CONFIDENCE FOR FUTURE

4 January 1993

HAFSLUND NYCOMED DOWNGRADED

7 December 1992

CONTRAST MEDIA MARKET SLOWDOWN EXPLAINED

7 December 1992

OMNISCAN APPROVED IN UK

5 October 1992

HAFSLUND NYCOMED 46% OPERATING PROFIT JUMP

17 February 1992

Showing 1-24 of 24 articles

Go to beginningPrevious
  • 1
NextGo to end